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YALE MEDICAL SOCIETY
November 8, 1950
OBSERVATION OF MALIGNANT CELLS IN VITRO. By Warfield Monroe
Firor, M. D., Associate Professor of Surgery, Johns Hopkins University.
Upon retransplantation of a laboratory-maintained twelve-year-old tissue
culture of fibroblasts from rat areolar tissue, a chance observation was that
some of the cells matured into the parent type while others spontaneously
became malignant sarcomatous cells. The factors responsible for the
malignant change are unknown. With the phase and electron microscopes,
minute cellular details can be observed and photographed. In contrast to
the normal fibroblasts, the malignant mesenchymal cells show few fila-
mentous processes at the cell perimeter. The latter also possess a character-
istic juxta-nuclear mass and an increased amount of fat globules. Nuclear
changes seem to precede cytoplasmic change in the transformation to the
malignant types. In one instance, the simultaneous death of a normal cell
in close proximity to a malignant cell undergoing mitosis was recorded on
film. It was postulated that this might be a possible mechanism for the
invasive properties of malignant tissues.
W. F. S.
ATYPICAL GROWTH RESEARCH UNIT
November 29, 1950
METASTASES IN CANCER. By Dale Rex Coman, Professor of Pathology,
University of Pennsylvania School of Medicine.
In cultures of human tissue there appeared to be more free-floating cells
in the neighborhood of tumor tissue than around normal tissue. This
observation led to experiments which showed that, by two different tech-
niques, tumor cells could be separated from one another more easily than
could normal cells. This looseness between tumor cells was said to be
"associated with" a low calcium content.
The number of metastases found in laboratory animals varied directly
with (1) the number of tumor cells injected, (2) the length of time a
transplanted tumor remained in the host, and (3) the initial size of that
transplant. The "soil hypothesis" of tumor growth was questioned on the
basis of experiments where injection of malignant cells into the femoral
vein of dogs led to metastases to leg muscle. Also, it appeared that malig-
nant cells could metastasize from the systemic veins to the bones of the
axis, skull, and pelvis-presumably through the vertebral venous plexus.
Finally, animal experiments in which stained cells and viable cells were
injected for comparison of their subsequent distribution demonstrated that
metastases occur in those tissues where embolic cells reach capillaries, and
not where the cells get only as far as the arterioles.
J. F. S.
PHARMACOLOGY SEMINAR
December 14, 1950
RECENT DEVELOPMENTS IN ANTIMICROBIAL THERAPY. By Lawrence B.
Hobson, M.D., Associate Medical Director, E. R. Squibb and Sons, New
York City.EVENTS
In clinical studies with the various antitubercular drugs, resistance of
Myco. tuberculosis to streptomycin has been found to occur within two
months if the antibiotic is administered daily. By administering 9 grams of
p-amino salicylic acid/day and 1-2 grams of streptomycin every fourth day,
the emergence of resistant strains of the tubercle bacillus has been delayed
for as long as one year. Toxicity symptoms of PAS-nausea, vomiting, and
diarrhea-have been ascribed to impurities in the drug. The sodium salt of
PAS may be injected subcutaneously with hyaluronidase or intravenously
with heparin in doses as high as 30-40 grams/day without the appearance
of toxic symptoms, indicating that the aforementioned toxic symptoms are
local effects. Tuberculosis meningitis has been treated recently with intra-
thecal injections of tuberculin and streptomycin. Although there is a dis-
turbing initial response, favorable results have been reported. Tibione in
the treatment of tuberculosis is less effective and more toxic than the initial
investigations indicated; neomycin and viomycin both cause 8th nerve
damage, the former giving rise to kidney disturbances as well; dihydro-
streptomycin produces more auditory damage but less vestibular damage
than streptomycin.
J. P. G.
YALE MEDICAL SOCIETY
January 4, 1951
THE CONTROL OF INFECTION IN BURNS. By Leonard Colebrook, formerly
Professor of Immunology and Bacteriology, St. Mary's Hospital Medical
School and the University of London.
Despite the known considerable benefits (e. g., earlier skin grafting) to
be derived from controlling infection in burns, chronic low grade infections
appear in almost all burn wounds during their treatment in hospitals at the
present time. Dr. Colebrook's thesis is that these chronic infections are
maintained largely by aerial cross-infection and can be greatly reduced by
changing burn dressings in a special, clean environment-not in dusty
open wards.
The degree of bacterial contamination of air and its variation with time
can be shown by means of a "slit sampler," an apparatus which draws air
through a brass cylinder, directing it outward against a blood agar plate in
such a manner that the growth later observed on any section of the plate
can be ascribed to the bacterial contamination of the air at a particular
moment. With this apparatus, one can appreciate the suddenly raised and
often qualitatively unique contamination arising from changing dressings
of infected burns. Also, since the level of contamination in an ordinary
room falls spontaneously only very slowly, the successive treatment of
many infections in the same room-as in an open ward, for example-
results in a greatly elevated level of contamination.
Ordinary outdoor air, however, is relatively free of bacteria and so the
special burn treatment room that Colebrook and his group are using is
simply a room that is continually flushed with clean air from the outside.
The air is filtered, heated, humidified, and directed obliquely downward
from the ceiling so as to provide a continual descending blanket of clean
air which is removed by an exhaust fan at the base of the wall. This is a
simple, inexpensive, and-the "slit sampler" has shown-effective measure,
for the bacterial contamination in such a room is negligible within half an
hour after a patient has been treated, the room then being ready for another
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patient. A record of swabs taken from dressings has given clinical eon-
firmation of the success of this procedure in combatting cross-infection.
Streptococcal infection, for example, which ordinarily reaches at least 30%o
has been kept below 5%o.
A seeming drawback to this measure is that the average single general
hospital does not receive enough cases of severe burns to warrant the
recommended preparation. This, however, only points to the need for the
establishment of properly prepared "burn centers" which would serve
considerably larger communities than does any single hospital.
R. G.
BEAUMONT MEDICAL CLUB
W. H. CARMALT LECTURE
January 5, 1951
ALMROTH WRIGHT, PIONEER IN IMMUNOLOGY AND THE KNOWLEDGE OF
WOUND INFECTION. By Leonard Colebrook, formerly Professor of Im-
munology and Bacteriology, St. Mary's Hospital Medical School and the
University of London.
A tribute to Wright emerged from this discussion of his work by his
former colleague. "A great thinker," his influence on the practice of medi-
cine seems to have escaped recognition in the textbooks, although he pub-
lished some two hundred papers and books. His scientific work falls roughly
into three periods. While Professor of Pathology at the Army Medical
School in England, he devised methods for the production and standardiza-
tion of typhoid vaccine, and was largely responsible for successful typhoid
vaccination in World War I. During a second period, at St. Mary's
Hospital, he studied the opsonic power of the infected patient's serum and
in many diseases used vaccine therapy to increase phagocytosis. Finally, his
attention was turned to the processes of wound healing, with particular
regard to the power of leucocytes to destroy organisms without phago-
cytosis. In addition to these accomplishments, Wright provided a stimulus
for the establishment of bacteriological laboratories in hospitals and con-
tributed numerous clever devices for experimental work. One example is
the Wright capsule for the removal of material from wounds.
Comment on his personality revealed him to be somewhat eccentric (in
a sense which prompted Cushing to call him "the G.B.S. of Medicine")
but a man of exceptional ingenuity, kindliness, and simplicity of purpose.
He was the kind of person who injected himself to prove the efficacy of
vaccine therapy. His contemporaries knew him as a scientist, an anti-
feminist, a philosopher, or the central figure of Shaw's Doctor's Dilemma.
Professor Colebrook would have us remember him as "an intellectual giant"
and a "great human being."
0. L. K.
PHARMACOLOGY SEMINAR
January 18, 1951
ADRENERGIC BLOCKADE AND SOME OF ITS APPLICATIONS. By Henry
Haimovici, Assistant Attending Surgeon, Montefiore Hospital, New York
City.
In search for chemical substances that will alleviate vasospasm of
autonomicorigin,fourmaintypes ofadrenergic blocking agents have evolved
-ergot alkaloids, imidazolines, benzodioxanes, and beta-haloalkylamines.
350Ergot alkaloids, in contrast to the others, act upon the vasomotor center
and vagal nuclei as well as demonstrating a peripheral adrenergic blocking
action. Imidazolines, represented by priscoline, cause vasodilatation by both
histaminergic activity and adrenergic blockade. Benzodioxanes, or the
Fourneau substances, are both sympatholytic and adrenolytic, since they
block conduction of impulses as well as the action of epinephrine at the
neuroeffector junction. The prototype of beta-haloalkylamines, dibenamine,
a substance which blocks the pressor action of epinephrine though not that
of angiotonin, reduces both systolic and diastolic pressures in some patients
with essential hypertension. The hypotensive action of this drug does not
appear until several hours after intravenous administration and its effect
persists for 24 to 72 hours. The postural hypotension and tachycardia
accompanying dibenamine therapy are minimal with a new analogue of
dibenamine, SKF-688F, which can be administered orally. Malignant
hypertension does not respond to any of these substances.
In patients with glaucoma refractory to the cholinergic drugs commonly
used, miosis, a reduction in ocular tension, and the relief of pain follow
from 5 to 6 hours after intravenous administration of dibenamine. The
drug acts upon the circular fibres of the ciliary muscle. In addition,
dibenamine will abolish hyperhidrosis, and although it is commonly believed
that cholinergic fibres alone cause sweating, investigations revealed that
epinephrine will induce sweating. Dibenamine blocks only the adrenergic
component of sweating.
J. P. G.
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